Publishing research using ab16646? Please let us know so that we can cite the reference in this datasheet.

ab16646 has been referenced in 7 publications.

  • Kim J  et al. Regulator of G-Protein Signaling 4 (RGS4) Controls Morphine Reward by Glutamate Receptor Activation in the Nucleus Accumbens of Mouse Brain. Mol Cells 41:454-464 (2018). PubMed: 29754475
  • Rodríguez-Muñoz M  et al. Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors. Oncotarget 9:23373-23389 (2018). PubMed: 29805740
  • Li J  et al. Differential Behavioral and Neurobiological Effects of Chronic Corticosterone Treatment in Adolescent and Adult Rats. Front Mol Neurosci 10:25 (2017). WB . PubMed: 28210212
  • Wu Q  et al. NR2B subunit of the NMDA glutamate receptor regulates appetite in the parabrachial nucleus. Proc Natl Acad Sci U S A 110:14765-70 (2013). PubMed: 23964123
  • Garzón J  et al. RGSZ2 Binds to the Neural Nitric Oxide Synthase PDZ Domain to Regulate Mu-Opioid Receptor-Mediated Potentiation of the N-Methyl-D-Aspartate Receptor-Calmodulin-Dependent Protein Kinase II Pathway. Antioxid Redox Signal 15:873-87 (2011). WB ; Mouse . PubMed: 21348811
  • Sánchez-Blázquez P  et al. Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling. PLoS One 5:e11278 (2010). WB ; Mouse . PubMed: 20585660
  • Bouzioukh F  et al. Tyrosine phosphorylation sites in ephrinB2 are required for hippocampal long-term potentiation but not long-term depression. J Neurosci 27:11279-88 (2007). PubMed: 17942722

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up